Table 3.
Effect of Flavo on cardiac troponin I (cTn-I) and brain GM-CSF in Cyclo injected mice
| Groups | Heart troponin I (pg/mg protein) | Brain GM-CSF (pg/mg protein) |
|---|---|---|
| Control | 48.5 ± 4.2 | 19.4 ± 1.9 |
| Flavo | 48.3 ± 0.2 | 18.35 ± 0.35 |
| Cyclo | 260.46 ± 9.1*$ | 54.73 ± 0.35*$ |
| Cyclo + Flavo | 92.5 ± 10.752# | 25.9 ± 3.1# |
Oral administration of (20 mg/kg) Flavocoxid (flavo) to mice from day 0 to 14 followed by Cyclophosphamide (Cyclo) intraperitoneal i.p (100 mg/kg) at day 14. Data were expressed as mean ± SED (n = 10). *, $, #, significantly different when compared to normal control, Flavo, and Cyclo groups, respectively, using one-way ANOVA test with Tukey Kramer post hoc test (p < 0.05)